I invite you to read my articles this month that appear in our Canadian Edition as the “Retail Investors’ Perspective” article discusses inflammation and how our change in diet and lifestyle combined with no longer consuming the potent anti-inflammatory compounds found in cannabis and hemp may be contributing to the rise of many preventable medical conditions. I present a hypothesis in that article that based on my research has not be undertaken anywhere to date. If that hypothesis were to be proven true it could prove transformative to our entire holistic approach to wellness and medical treatment options. This medical study, for example, details how cannabis has been used since ancient times for inflammatory bowel disease.
I also encourage you to read my exclusive Q&A with world removed wellness Dr. Sunil Pai that immediately follows this article.
If you have come away from this article with the impression that I did not discuss investing at al then read it again. The Constellation deal is just the beginning. Molson Coors announced it was taking a stake in Licensed Producer, The Hydropothecary Corporation. Heineken has also entered the cannabis space. In 2016 when we were the first to discuss and predict how infused beverages would be a game changer, we included the prediction that large alcohol companies will enter the space and likely through M&A of established well developed producers. And here we are … as you know, we connect the dots before the others do.
149
Of course the real test is how has the share price of Canopy responded to this?